Some 200 women in the UK who have reported being left in pain after having a – now discontinued – permanent contraceptive coil fitted (as opposed to the IUD and IUS, which can be removed at any time), ...

Even though it's no longer on the market, new data has emerged around potential side effects of the permanent birth control device Essure. The device, pulled from the US market two years ago amid ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

WASHINGTON, D.C. (WPVI) -- A local congressman says the FDA grossly underestimated the harm caused by a contraceptive device. And he alleges the maker paid doctors kickbacks to recommend the device to ...

Thousands of women have complained to FDA about abdominal pain, headaches, and other complications after having the Essure coils implanted in their fallopian tubes. Qmed Staff U.S. FDA's Obstetrics ...

Since it was approved to go on the market in 2002, Essure, an implantable permanent contraceptive device, has been plagued by controversy. Thousands of women have filed grievances with the US Food and ...

Two hundred women in the UK who claim they were left in pain after having a permanent contraception device fitted, can now take group legal action through the courts, against its manufacturer. The ...

Essure birth control was first approved in 2002. — -- U.S. regulators said they would review a popular birth control implant device at a panel this week following multiple complaints. The implant ...

NEW YORK, July 20 (Reuters) - Healthcare company Bayer on Friday said it would discontinue the sale of its birth control product Essure in the United States, citing a decline in sales of the ...

When Alyson Hannan, 44, decided she was done having children, she chose Essure, a nonsurgical permanent birth control option approved by the Food and Drug Administration. The day the tiny metal coils ...

At the request of the Food and Drug Administration, Leverkusen, Germany-based Bayer will now add a box warning and patient decision checklist to the label of its permanent birth control device Essure.